CRESCENT BIOPHARMA, INC. Common Stock Shares Outstanding

Quick Answer

CRESCENT BIOPHARMA, INC. reported Common Stock Shares Outstanding of 27.56 million shares for the year ending 2025.

  • CRESCENT BIOPHARMA, INC. showed an increase of +2,605.3% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from CRESCENT BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: 18.78 million shares | Q2 2014: 18.89 million shares | Q3 2014: 18.89 million shares | Q1 2015: 19.01 million shares | Q2 2015: 19.02 million shares | Q3 2015: 19.04 million shares | Q1 2016: 19.28 million shares | Q2 2016: 23.03 million shares | Q3 2016: 23.06 million shares | Q1 2017: 23.86 million shares | Q2 2017: 32.72 million shares | Q3 2017: 32.74 million shares | Q1 2018: 42.49 million shares | Q2 2018: 43.06 million shares | Q3 2018: 43.14 million shares | Q1 2019: 43.18 million shares | Q2 2019: 43.19 million shares | Q3 2019: 43.36 million shares | Q1 2020: 43.58 million shares | Q2 2020: 46.71 million shares | Q3 2020: 47.83 million shares | Q1 2021: 51.54 million shares | Q2 2021: 51.54 million shares | Q3 2021: 51.74 million shares | Q1 2022: 51.74 million shares | Q2 2022: 52.42 million shares | Q3 2022: 52.42 million shares | Q1 2023: 64.25 million shares | Q2 2023: 64.31 million shares | Q3 2023: 64.37 million shares | Q1 2024: 64.45 million shares | Q2 2024: 64.48 million shares | Q3 2024: 64.48 million shares | Q1 2025: 64.53 million shares | Q2 2025: 13.89 million shares | Q3 2025: 13.89 million shares.
  • Over the full 13 years of available data (2013 to 2025), CRESCENT BIOPHARMA, INC.'s Common Stock Shares Outstanding has grown by 1,831.6%.
  • Historical annual values: Fiscal year 2025: 27.56 million shares | Fiscal year 2024: 1.02 million shares | Fiscal year 2023: 64.39 million shares | Fiscal year 2022: 54.38 million shares | Fiscal year 2021: 52.31 million shares | Fiscal year 2020: 49.02 million shares | Fiscal year 2019: 43.47 million shares | Fiscal year 2018: 43.16 million shares | Fiscal year 2017: 34.36 million shares | Fiscal year 2016: 23.25 million shares | Fiscal year 2015: 19.05 million shares | Fiscal year 2014: 18.94 million shares | Fiscal year 2013: 1.43 million shares.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: